Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
Molina-Pinelo S, Ferrer I, Blanco-Aparicio C, Peregrino S, Pastor MD, Alvarez-Vega J, Suarez R, Verge M, Marin JJ, Hernandez-Losa J, Ramon y Cajal S, Paz-Ares L, Carnero A. Molina-Pinelo S, et al. Among authors: marin jj. J Pathol. 2011 Sep;225(1):73-82. doi: 10.1002/path.2905. Epub 2011 May 19. J Pathol. 2011. PMID: 21598252
Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
Ferrer I, Verdugo-Sivianes EM, Castilla MA, Melendez R, Marin JJ, Muñoz-Galvan S, Lopez-Guerra JL, Vieites B, Ortiz-Gordillo MJ, De León JM, Praena-Fernandez JM, Perez M, Palacios J, Carnero A. Ferrer I, et al. Among authors: marin jj. Oncogene. 2016 May;35(21):2777-88. doi: 10.1038/onc.2015.341. Epub 2015 Sep 21. Oncogene. 2016. PMID: 26387546
Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.
Verdugo-Sivianes EM, Navas L, Molina-Pinelo S, Ferrer I, Quintanal-Villalonga A, Peinado J, Garcia-Heredia JM, Felipe-Abrio B, Muñoz-Galvan S, Marin JJ, Montuenga L, Paz-Ares L, Carnero A. Verdugo-Sivianes EM, et al. Among authors: marin jj. Oncotarget. 2017 Oct 26;8(62):105196-105210. doi: 10.18632/oncotarget.22111. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285244 Free PMC article.
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
Guijarro MV, Vergel M, Marin JJ, Muñoz-Galván S, Ferrer I, Ramon y Cajal S, Roncador G, Blanco-Aparicio C, Carnero A. Guijarro MV, et al. Among authors: marin jj. Oncogene. 2012 Oct 11;31(41):4447-59. doi: 10.1038/onc.2011.619. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266858
Cellular senescence as a target in cancer control.
Vergel M, Marin JJ, Estevez P, Carnero A. Vergel M, et al. Among authors: marin jj. J Aging Res. 2010 Dec 30;2011:725365. doi: 10.4061/2011/725365. J Aging Res. 2010. PMID: 21234095 Free PMC article.
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S, Felipe-Abrio B, García-Carrasco M, Domínguez-Piñol J, Suarez-Martinez E, Verdugo-Sivianes EM, Espinosa-Sánchez A, Navas LE, Otero-Albiol D, Marin JJ, Jiménez-García MP, García-Heredia JM, Quiroga AG, Estevez-Garcia P, Carnero A. Muñoz-Galván S, et al. Among authors: marin jj. J Exp Clin Cancer Res. 2019 Jun 3;38(1):234. doi: 10.1186/s13046-019-1245-5. J Exp Clin Cancer Res. 2019. PMID: 31159852 Free PMC article.
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Payo-Serafín T, Méndez-Blanco C, Fernández-Palanca P, Martínez-Geijo J, Reviejo M, Ortiz-de-Urbina JJ, González-Gallego J, Marin JJG, Mauriz JL, San-Miguel B. Payo-Serafín T, et al. Among authors: marin jjg. Clin Pharmacol Ther. 2024 May 27. doi: 10.1002/cpt.3312. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38803056 Review.
307 results